Public, NASDAQ:GENE
NASDAQ Global Market
Much Higher Than Normal Volume: MITI, RNWK, MNTA, ENMD, GENE, CRR, TSRX, MLNX
Date: Thu, 26 Jan 2012 15:53:46 GMT
Tags:
Much Higher Than Normal Volume: MITI, RNWK, MNTA, ENMD, GENE, CRR, TSRX, MLNX
TomRollins.com - Jan 26, 2012
TomRollins.com - Jan 26, 2012
Micromet Inc. (Public, NASDAQ:MITI). Last Market Price: $10.93, Change +2.65, % Change (32.00%). Shares trade in the range of $10.90 - $10.95 dollars.
Top 10 Rebounding Biotech Stocks: IDIX, MDVN, PCYC, REGN, JAZZ, GENE, ELN ...
Date: Tue, 24 Jan 2012 15:19:37 GMT
Tags:
Top 10 Rebounding Biotech Stocks: IDIX, MDVN, PCYC, REGN, JAZZ, GENE, ELN ...
China Analyst - Jan 24, 2012
China Analyst - Jan 24, 2012
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) is the 1st best rebounding stock in this segment of the market. It has risen 417% from its 52-week low.
Genetic Technologies Limited Launches BREVAGen Breast Cancer Risk Test In US
Date: Sun, 19 Jun 2011 22:45:00 GMT
Tags:
Genetic Technologies Limited Launches BREVAGen Breast Cancer Risk Test In US
Reuters Key Development - Jun 19, 2011
Reuters Key Development - Jun 19, 2011
Genetic Technologies Limited Files New Patent Infringement Suit In USA
Date: Thu, 26 May 2011 11:16:00 GMT
Tags:
Genetic Technologies Limited Files New Patent Infringement Suit In USA
Reuters Key Development - May 26, 2011
Reuters Key Development - May 26, 2011
Genetic Technologies Limited Secures US Approval For Launch Of BREVAGen Breast Cancer Risk Test
Date: Wed, 27 Apr 2011 00:37:00 GMT
Tags:
Genetic Technologies Limited Secures US Approval For Launch Of BREVAGen Breast Cancer Risk Test
Reuters Key Development - Apr 27, 2011
Reuters Key Development - Apr 27, 2011
InPlay: Genetic Technologies executes settlement and license agreement with Eurofins STA Laboratories
Date: Mon, 06 Feb 2012 18:03:48 GMT
Tags:
Genetic Technologies Executes Settlement and License Agreement With Eurofins STA Laboratories, Inc.
Date: Mon, 06 Feb 2012 18:00:00 GMT
Tags:
[Marketwire] - MELBOURNE, AUSTRALIA-- - In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited is pleased to report that it has executed a Settlement and License Agreement with Eurofins STA ...
Genetic Technologies Files Quarterly Activities Report and ASX Appendix 4C for Quarter Ended December 31, 2011
Date: Tue, 31 Jan 2012 10:15:00 GMT
Tags:
[Marketwire] - MELBOURNE, AUSTRALIA-- - Genetic Technologies Limited today announced it has filed its Quarterly Activities Report and Appendix 4C for period ending December 31, 2011 in accordance with the ASX.Total cash ...
8 Stocks Under $10 Ripping Higher
Date: Thu, 26 Jan 2012 19:32:02 GMT
Tags:
Genetic Technologies Appoints Dr. Mel Bridges as Chairman
Date: Fri, 16 Dec 2011 10:15:00 GMT
Tags:
[Marketwire] - MELBOURNE, AUSTRALIA-- - The Board of Directors of Genetic Technologies Limited has with great pleasure appointed Dr. Mel Bridges as Chairman and non-executive Director of the Company.Mel Bridges has over ...